1. Home
  2. NFE vs IMRX Comparison

NFE vs IMRX Comparison

Compare NFE & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo New Fortress Energy Inc.

NFE

New Fortress Energy Inc.

HOLD

Current Price

$6.32

Market Cap

324.4M

Sector

Utilities

ML Signal

HOLD

Logo Immuneering Corporation

IMRX

Immuneering Corporation

HOLD

Current Price

$4.30

Market Cap

313.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NFE
IMRX
Founded
2014
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Oil/Gas Transmission
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
324.4M
313.8M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
NFE
IMRX
Price
$6.32
$4.30
Analyst Decision
Buy
Strong Buy
Analyst Count
3
5
Target Price
$5.50
★ $17.20
AVG Volume (30 Days)
★ 2.4M
658.0K
Earning Date
04-13-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 37.75
EPS
N/A
★ N/A
Revenue
★ $1,504,037,000.00
N/A
Revenue This Year
$110.34
N/A
Revenue Next Year
$3.54
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.23
$3.86
52 Week High
$16.90
$8.48

Technical Indicators

Market Signals
Indicator
NFE
IMRX
Relative Strength Index (RSI) 53.51 39.99
Support Level $0.61 $3.98
Resistance Level $16.90 $5.32
Average True Range (ATR) 1.14 0.20
MACD 0.03 -0.03
Stochastic Oscillator 34.45 15.79

Price Performance

Historical Comparison
NFE
IMRX

About NFE New Fortress Energy Inc.

New Fortress Energy Inc is an integrated gas-to-power company. Its business model spans the entire production and delivery chain from natural gas procurement and liquefaction to logistics, shipping, terminals, and conversion or development of a natural gas-fired generation. It has invested in floating, liquefied natural gas vessels to lower the cost of acquiring gas while securing a long-term supply for its terminals. Its segments include Terminals & Infrastructure, and Ships. It generates the majority of its revenue from the Terminals & Infrastructure segment.

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

Share on Social Networks: